` TRIB (Trinity Biotech PLC) vs S&P 500 Comparison - Alpha Spread

TRIB
vs
S&P 500

Over the past 12 months, TRIB has outperformed S&P 500, delivering a return of +27% compared to the S&P 500's +13% growth.

Stocks Performance
TRIB vs S&P 500

Loading
TRIB
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TRIB vs S&P 500

Performance Gap Between TRIB and GSPC
HIDDEN
Show

Performance By Year
TRIB vs S&P 500

Loading
TRIB
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Trinity Biotech PLC vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Trinity Biotech PLC
Glance View

Market Cap
21.9m USD
Industry
Health Care

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

TRIB Intrinsic Value
HIDDEN
Show
Back to Top